Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Neijt

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|October 1, 1996
Gemcitabine in cisplatin-resistant ovarian cancerB Lund, J P Neijt
Seminars in Oncology|December 1, 1996
Paclitaxel with carboplatin for the treatment of ovarian cancerJ P Neijt, B Lund
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1988
[Consensus follow-up study after surgery for colonic or rectal carcinoma]J P Neijt, K Welvaart
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Aspects of surgery in ovarian and endometrial carcinomaJ G Aalders, J P Neijt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Neural network analysis to predict treatment outcomeH J Kappen, J P Neijt
Seminars in Oncology|April 6, 1999
Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancerJ P Neijt, A du Bois
Journal of the National Cancer Institute|March 7, 1990
Comparing cisplatin and carboplatinJ P Neijt, J C van Houwelingen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?E A Eisenhauer, M Gore, J P Neijt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?A du Bois, J P Neijt, J T Thigpen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neurotoxic side-effects of cisplatinF P Harmers, W H Gispen, J P Neijt
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|October 1, 1996
Gemcitabine in cisplatin-resistant ovarian cancerB Lund, J P Neijt
Seminars in Oncology|December 1, 1996
Paclitaxel with carboplatin for the treatment of ovarian cancerJ P Neijt, B Lund
Nederlands Tijdschrift Voor Geneeskunde|July 23, 1988
[Consensus follow-up study after surgery for colonic or rectal carcinoma]J P Neijt, K Welvaart
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Aspects of surgery in ovarian and endometrial carcinomaJ G Aalders, J P Neijt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Neural network analysis to predict treatment outcomeH J Kappen, J P Neijt
Seminars in Oncology|April 6, 1999
Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancerJ P Neijt, A du Bois
Journal of the National Cancer Institute|March 7, 1990
Comparing cisplatin and carboplatinJ P Neijt, J C van Houwelingen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?E A Eisenhauer, M Gore, J P Neijt
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?A du Bois, J P Neijt, J T Thigpen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neurotoxic side-effects of cisplatinF P Harmers, W H Gispen, J P Neijt
Pageof 10